With this year’s Annual Meeting of the American Academy of Neurology (AAN) just days away, researchers and clinicians from around the world will come together and share their latest findings with the global neurology community.
Held in Boston from April 22-28, this year’s meeting will play host to over 10,000 neurology professionals and over 2700 abstracts covering cutting-edge science, from preclinical research to extended analyses of currently available therapeutics.
Bridging the gap between research and clinical application is a major theme of the meeting, as evident in the new “Neuroscience in the Clinic” sessions.
“Until recently, neuroscientists and clinicians moved for the most part in separate spheres. AAN is making a concerted effort to invest in connecting basic science developments to the clinical level, as clinicians are now more invested in basic science advances as they affect patient care,” said Albert Favate, MD, co-director of the Comprehensive Stroke Center at NYU Langone Medical Center and a member of Neurology Advisor‘s Editorial Advisory Board. “These changes may lead to newer treatment modalities, shorter therapeutic trials, and hopefully better patient outcomes.”
Further, a clinical discussion session has been added to the Scientific Platform presentations, “which is designed to put the cutting-edge scientific data into the clinical application context and to stimulate ‘bench-to-bedside’ conversations, which we hope will lead to advancing the scientific discoveries into cures for our neurology patients,” said Natalia Rost, MD, MPH, FAAN, FAHA, vice chair of the AAN science committee.
This year’s meeting will also offer a more user-friendly poster session experience thanks to the development of topic “neighborhoods,” which will make navigating the thousands of abstracts much easier for attendees.
The meeting’s plenary sessions will feature a star-studded list of guest lecturers on various topics, including improving outcomes in epilepsy and early diagnosis of Alzheimer’s. The program also includes the popular “Controversies in Neurology” plenary session, in which leaders in the field argue for or against several topics, including whether focused ultrasound is better than deep brain stimulation, and whether disease-modifying drugs should be stopped in progressive multiple sclerosis.
Other sessions and topics of interest as indicated by Dr Favate include forums on management and education for neurologists-in-training, less exciting but necessary sessions on ICD 10/CPT coding updates, since “correct code use is critical to practice survival,” he said, and practice management updates for hospitals and accountable care organizations.
Stay with Neurology Advisor for live updates from the meeting, including in-depth articles on the latest research and video interviews with leaders in the field. Coverage begins Sunday, April 23, 2017.